CJC-1295 vs Tesamorelin
Broad GHRH analog vs visceral-fat-focused analog.
| Attribute | CJC-1295 GHRH analog | Tesamorelin Stabilized GHRH analog |
|---|---|---|
| Category | Muscle Growth & Performance | Muscle Growth & Performance |
| Best known for | Sustained GHRH stimulation research | Visceral fat reduction research |
| In plain English | If ipamorelin opens the GH faucet, CJC-1295 widens the pipe. Together they produce larger natural GH pulses. | Tesamorelin is the GH peptide with the strongest data for shrinking visceral (belly) fat specifically. |
| How it works | Activates the GHRH receptor in the pituitary, increasing the amplitude of natural GH pulses. | Activates GHRH receptors, increasing GH and IGF-1 with documented preferential effects on visceral adipose tissue. |
| Researchers study | GH secretion, IGF-1 levels, body composition, and sleep architecture. | Visceral fat reduction, lipid metabolism, and cognitive function in older adults. |
| Internet discussion | DAC vs no-DAC is the eternal forum debate. | Discussed by people specifically targeting belly fat. |
CJC-1295
Sustained GHRH stimulation research
If ipamorelin opens the GH faucet, CJC-1295 widens the pipe. Together they produce larger natural GH pulses.
Activates the GHRH receptor in the pituitary, increasing the amplitude of natural GH pulses.
GH secretion, IGF-1 levels, body composition, and sleep architecture.
DAC vs no-DAC is the eternal forum debate.
CJC-1295 is a GHRH analog that amplifies natural GH pulses, especially when paired with a ghrelin mimetic.
Tesamorelin
Visceral fat reduction research
Tesamorelin is the GH peptide with the strongest data for shrinking visceral (belly) fat specifically.
Activates GHRH receptors, increasing GH and IGF-1 with documented preferential effects on visceral adipose tissue.
Visceral fat reduction, lipid metabolism, and cognitive function in older adults.
Discussed by people specifically targeting belly fat.
Tesamorelin is the GHRH analog with strongest data for reducing visceral fat specifically.